Pharma has a lot to be proud of. In the last ten months, the industry has stepped up to deal with the consequences of COVID-19, without neglecting other disease indications. Below, you’ll find a selection of articles that showcase how the industry continues to flourish – from innovation in the ADC sector, to R&D wins in immunology research. What are your predictions for the year ahead? Let us know. Till next time, Maryam Mahdi, Associate Editor.
|